New study aims to stop Post-Birth bleeding with smarter drug dosing

NCT ID NCT05370820

First seen Nov 03, 2025 · Last updated May 30, 2026 · Updated 34 times

Summary

This study looks at how to best use the drug tranexamic acid (TXA) to prevent postpartum hemorrhage (severe bleeding after childbirth). Researchers will test different doses and ways of giving the drug (by IV or injection) in about 120 women having a C-section or vaginal delivery. The goal is to find the safest and most effective dose to prevent dangerous bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST PARTUM HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • George Washington University Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20037, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Inova Fairfax Medical Campus

    RECRUITING

    Falls Church, Virginia, 22042, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.